5 Keys to a Deck that Delivers

On February 4, 2020   /   Opus Blog  
5 Keys to a Deck that Delivers

5 Keys to a Deck That Delivers Advice for Biotech CEOs from Daniel Eramian, Co-founder of Opus Biotech Communications Heading to BIO CEO Investors Conference or another Investors Presentation? Here are five important points to keep in mind when finalizing your pitch deck. 1.  Design your slides for the audience. Investors may sit in on scores of presentations so you want them to remember yours. Using a slide-deck for a one-on-one meeting is different than presenting slides to an audience in a large room. 2. Don’t overload each slide with needless words. White space is good. Each slide should have one main message. Verbally repeat that message to the audience at the end of each slide. 3. If your presentation time is 12 minutes, have no more than 12 slides. Take one minute per slide to discus the key point (s) . 4. Always include a slide on the opportunity

Read more →
Back to Top

Building Trust Can Be Money in the Bank for Biotechs

On March 20, 2018   /   Opus Blog  

Ask a CEO who is in charge of his or her company and they won’t blink before saying, “I am.” Ask that same CEO who is in charge of the company’s credibility you might get a different answer such as, “that’s the PR department’s job.”   Whether you are a first-time entrepreneur or a veteran company executive, one vital aspect of growing a business, raising capital, or selling a product that’s rarely discussed at seminars is building your company’s credibility, reputation and trust. Because it is not easy to measure these important qualities in dollars and cents, they rarely get much attention in quarterly reports.  Busy CEOs charged with concentrating on bottom line finances and product advancement don’t always see the connection. Big Pharma companies rely mostly on tangible assets and accomplishments in their efforts to build credibility and reputation. For most biotechs, paydays and tangible assets can be a

Read more →
Back to Top